{"adverse_reactions":["ADVERSE REACTIONS No adverse events have been reported with a casual relationship to Cralonin oral vials"],"clinical_pharmacology":["CLINICAL PHARMACOLOGY Mechanism of Action The exact mechanism of Cralonin oral vial is not fully understood"],"contraindications":["CONTRAINDICATIONS Cralonin oral vials are contraindicated in patients with known sensitivity to Cralonin or any of its ingerdients."],"description":["DESCRIPTION Each 1.1 ml ampule contains: Ingedient Potency Quantity Crataegus oxyacantha 2X 11µ Spigelia anthelmia 1X 11µ Kali carbonicum 2X 11µ Inactive Ingedient: Isotonic Sodium chloride solution"],"description_table":["
Ingedient Potency Quantity
Crataegus oxyacantha 2X 11µ
Spigelia anthelmia 1X 11µ
Kali carbonicum 2X 11µ
"],"dosage_and_administration":["DOSAGE AND ADMINISTRATION Adults: In general, 1 vial 1-3 times daily orally by mouth."],"dosage_forms_and_strengths":["Dosage 1 oral vial containing 1.1 ml solution for oral administration"],"effective_time":"20140818","id":"d856e3bd-c785-4107-932a-c8beb17f2499","indications_and_usage":["INDICTION AND USAGE Cralonin indicated for the ancillary treatment of myocardial weakness"],"openfda":{},"overdosage":["OVERDOSAGE Overdosage: No negative effects of an overdose have been reported"],"package_label_principal_display_panel":["Cralonin oral vial.jpg"],"set_id":"3242c8d5-ef16-40f7-91e7-ab7605a6b691","spl_product_data_elements":["Cralonin CRATAEGUS LAEVIGATA FLOWER, SPIGELIA ANTHELMIA and POTASSIUM BROMIDE CRATAEGUS LAEVIGATA FLOWER CRATAEGUS LAEVIGATA FLOWER SPIGELIA ANTHELMIA SPIGELIA ANTHELMIA POTASSIUM BROMIDE BROMIDE ION SODIUM CHLORIDE"],"version":"2","warnings_and_cautions":["WARNINGS AND PRECAUTIONS Warnings and Precautions None"]}